Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162631 | SCV000213066 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000227327 | SCV000285923 | likely benign | Familial adenomatous polyposis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000227327 | SCV000487379 | likely benign | Familial adenomatous polyposis 2 | 2016-09-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162631 | SCV000685563 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-23 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759159 | SCV000888305 | likely benign | not provided | 2019-04-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000504500 | SCV001338659 | likely benign | not specified | 2020-04-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000759159 | SCV001882923 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000504500 | SCV002552530 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000227327 | SCV004843462 | likely benign | Familial adenomatous polyposis 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000759159 | SCV000592676 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000162631 | SCV000788063 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004544479 | SCV004771892 | likely benign | MUTYH-related disorder | 2019-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |